Beirne Wealth Consulting Services »

Madrigal Pharmaceuticals shares owned by Beirne Wealth Consulting Services

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Beirne Wealth Consulting Services from 13F filings

Historical chart of Beirne Wealth Consulting Services investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Beirne Wealth Consulting Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Beirne Wealth Consulting Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $233k 508 458.67

More positions owned by Beirne Wealth Consulting Services

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr U S Equity Factr (LRGF)
Ishares Tr Rus 1000 Val Etf (IWD)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Small Cp Etf (VB)
Microsoft Corporation (MSFT)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Msci Acwi Etf (ACWI)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Beirne Wealth Consulting Services

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Rtw Investments
Paulson & Co
Henderson Group
venBio Select Advisor
Vanguard Group
BlackRock
State Street Corporation
Geode Capital Management
William Blair Investment Management
Wellington Management Company
FMR
Goldman Sachs Group
Susquehanna International
Invesco

View all funds holding Madrigal Pharmaceuticals